Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Cloud Tour of “China Pathology Annual Conference” – A Sneak Peek at MX3D’s Exhibition Hall

Continue reading
06 2 月

Tumor Talk: Why Pathology Matters

Continue reading
06 2 月

Pathology News Weekly Issue 3

Continue reading
06 2 月

Deputy Director Wang Xiang of the High-Tech Department of the National Development and Reform Commission and Other Leaders Visit Maixin for Research and Guidance

Continue reading
06 2 月

The Role of Descriptive Pathology Reports is Often Overlooked in the Fast-Paced World of Diagnosis

Continue reading
06 2 月

Tumor Talk: Diagnosis of Tumors

Continue reading
06 2 月

Green Environmental Protection Starts with Me, I Contribute Love to Green

Continue reading
06 2 月

Role of SMA Expression in Different Tumors

Continue reading
06 2 月

With the Right Chip Comes Mastery, the Motherland Cannot Save You Every Time

Continue reading
06 2 月

Pathology Weekly Reading Notes Episode 5: Immunohistochemical Markers for Diagnosing Epithelial Tumors (Part 2)

Continue reading
  • «
  • ‹
  • 20
  • 21
  • 22
  • 23
  • 24
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar